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PCR/ESI-MS of BAL fluid followed by EV-D68–spe-
cific PCR testing of 1 nasopharyngeal swab and 2 BAL 
fluid samples confirmed our clinical suspicion of ARDS 
secondary to EV-D68 in an adult. The patient’s history of 
contact with sick family members and clinical signs (non-
productive cough, nausea, and vomiting) were suggestive 
of a viral infection. Lessons learned from the emergence of 
swine-origin influenza A(H1N1)pdm09 virus and recogni-
tion (in the midst of the pandemic) that younger age and 
obesity were risk factors for severe disease were also sug-
gestive of a viral respiratory infection.
We are developing a specific rapid molecular assay 
for EV-D68, which should help clinicians recognize when 
EV-D68 is present in the community. During those times, 
EV-D68 infection should be included in the differential di-
agnosis of severe respiratory infection. Documentation of 
EV-D68 infection may help with clinical management for 
individual patients and minimize unnecessary use of anti-
microbial drugs within communities.
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To the Editor: Over the past 4 years, outbreaks caused 
by enterovirus type D68 (EV-D68) infection have occurred 
in many parts of the world (1); this virus can cause severe 
respiratory tract infections (RTIs) in children. This public 
health concern has been boosted by the recent outbreaks 
of EV-D68 infection in the United States (http://www.cdc.
gov/non-polio-enterovirus/outbreaks/EV-D68-outbreaks.
html). Outbreaks associated with novel EV-D68 have also 
been reported during 2006–2012 in China (2,3). Howev-
er, since 2012, no EV-D68 infections in China have been 
reported. Whether the EV-D68 outbreaks in the United 
States affected those in China is unclear. Continuous char-
acterization of EV-D68 epidemics is therefore necessary 
for purposes of early alert and for facilitating control mea-
sure decisions.
To determine EV-D68 prevalence in China, we 
screened for EV-D68 infections in 2014 in Beijing, Chi-
na. We tested patients with RTI during August–November 
2014, reported by the Respiratory Virus Surveillance Sys-
tem, established by Beijing Center for Disease Prevention 
and Control. The System covers 30 sentinel hospitals in all 
16 districts of Beijing. We obtained 1,478 clinical speci-
mens (1,034 nasopharyngeal swab and 444 sputum). Pa-
tient ages ranged from 8 months to 93 years (median 33.5 
years, mean 37.9 years). Enteroviruses and other known 
respiratory viruses were detected by real-time PCR (4). A 
total of 70 enterovirus-positive samples were identified. 
Other respiratory viruses detected were 89 rhinoviruses, 87 
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influenza viruses, 70 human parainfluenza viruses (types 
1–4), 43 human coronaviruses, 26 respiratory syncytial 
viruses, 29 adenoviruses, 9 bocaviruses, and 2 metapneu-
moviruses. Among the EV-positive samples, 1 was positive 
for EV-D68 according to PCR amplification of the viral 
protein 1 (VP1) gene (5); no other respiratory viruses were 
detected in this patient. 
The EV-D68–positive patient was a 5-year-old girl 
with no underlying disease. On August 5, 2014, she had 
fever (highest temperature 40°C), cough, breathing diffi-
culty, abdominal pain, diarrhea, and vomiting. Her condi-
tion deteriorated, and on August 11, she was hospitalized 
in Beijing Children’s Hospital with a diagnosis of severe 
pneumonia. A nasopharyngeal swab sample was collected 
at the time of admission. She was released on August 16, 
after receiving symptomatic supportive treatment in the 
general ward; she had not required mechanical ventilation. 
She and her family had no history of travel in the months 
before she became ill.
To further characterize this virus strain, Beijing-
R0132, we amplified the genome sequence directly from 
a nasopharyngeal swab sample by using overlapping prim-
ers designed according to the reference sequence (Gen-
Bank accession no. KM892501; online Technical Appendix, 
http://wwwnc.cdc.gov/EID/article/21/5/15-0036-Techapp1.













determined by using the RACE System  (Invitrogen, Carls-
bad, CA, USA) according to the manufacturer’s proto-
col. Each amplicon was sequenced 4 times by using the 
Sanger method, and the forward and reverse sequences 
agreed well. Sequences were assembled by using DNA-
Star software (Lasergene, Madison, WI, USA) and depos-
ited in GenBank (accession no. KP240936). The genome 
of Beijing-R0132 was 7,334 nt long, including 699 nt in 
5′-untranslated regions (5′-UTRs), 6,567 nt in open read-
ing frame (ORF), and 68 nt in 3′-UTR. Beijing-R0132 
shared 96% nt sequence identity with the virus circulat-
ing in the United States in 2014, US/CO/14-60. In con-
trast to the prototype EV-D68 (Fermon strain, AY426531), 
deletions of the CTCAAAACCTCCAGTACATAACA se-
quence in the 5′-UTR and TTATTTATAACA sequence in 
the front of the ORF of Beijing-R0132 were observed, cor-
responding with nt 682–704, and nt 721–732 of the Fermon 
strain, which were similar to those identified in the United 
States in 2014.
We then used MEGA software version 6.06 (http://
www.megasoftware.net) to analyze the phylogeny of 
the whole genome and the VP1 gene with EV-D68 se-
quences available in GenBank (Figure). Beijing-R0132 
was clustered with most of the EV-D68 strains that cir-
culated throughout the United States during 2014. The 
strains identified from Beijing in 2008, represented by 
BCH895A/2008, belong to another distinct lineage ac-
cording to genome phylogeny (Figure, panel A). Similar 
relationships were observed in the phylogenic tree of the 
VP1 gene (Figure, panel B). Beijing-R0132 and some EV-
D68 strains from China identified in 2011 grouped with 
most of the strains obtained from the United States in 
2014. These findings demonstrate that the EV-D68 strain 
circulating in Beijing was closely related to strains circu-
lating in the United States.
The origin of the 2014 EV-D68 outbreaks in the Unit-
ed States is unclear. This Beijing-R0132 genome sequence 
provides information for tracking EV-D68 as it spreads 
throughout the world and for evaluating the sequence di-
versity in circulating EV-D68 strains. In contrast to EV-D68 
detection during the outbreaks in the United States, positive 
detection of EV-D68 in this study was limited, although the 
circulating virus strains were closely related. The reason 
for this disparity warrants further investigation. However, 
the severe pneumonia caused by EV-D68 reported here 
underlies the need for intensive attention to surveillance 
and control of EV-D68 in vulnerable populations, such as 
young children. In addition, for a megacity with very high 
population density and mobility, such as Beijing, the city-
wide implementation of the Respiratory Virus Surveillance 
System is critical for monitoring the epidemic or potential 
outbreaks of EV-D68 and other respiratory viruses and for 
enabling early warning.
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Correction: Vol. 21, No. 4
The Continuing Medical Education quizzes for 2 
articles were inadvertently omitted from the April issue. 
The quizzes are printed at the back of this issue, and 
the complete articles and quizzes are available online 
(http://wwwnc.cdc.gov/eid/article/21/4/14-1479_intro and 
http://wwwnc.cdc.gov/eid/article/21/4/14-1033_intro).
